Popular Articles

Researchers Urge Individuals To Adopt Healthier Lifestyles, Particularly In Middle Age
Despite the well-known benefits of having a lifestyle that includes physical activity, eating a diet high in fruits and vegetables, maintaining a healthy weight, moderate alcohol use and not smoking, only a small proportion of adults follow this healthy lifestyle pattern, and in fact, the numbers are declining, according to an article published in the June 2009 issue of The American Journal of Medicine. Lifestyle choices are associated with the risk of cardiovascular disease as well as diabetes.

General Practices Should Carry Out Majority Of Swine Flu Vaccinations
Australia"s general practices stand ready to work with Government to begin vaccinating vulnerable Australians against HINI (Swine Flu) as soon as a vaccine becomes available, the AMA said today.
News of the day
UK Charity Tackles Health Risk For Children - Engaging Website Launches To Educate Children At A Crucial Age In Bone Development
Research from the National Osteoporosis Society has revealed that almost half (49%)* of young people do not know that there are steps they can take to keep their bones healthy. This knowledge gap puts them at risk of osteoporosis and fractures in later life.
Medical Devices

Cost-Effectiveness Of HPV Vaccination In The Netherlands

Even under favorable assumptions, including lifelong protection against 70% of all cervical cancers and no side effects, vaccination against the human papillomavirus (HPV) is not cost-effective in the Netherlands, according to a study published online July 1 in the Journal of the National Cancer Institute. Researchers conducted the study because the cost effectiveness of HPV vaccination may be limited by the low number of cervical cancer cases and deaths in the region associated with the current Dutch cervical cancer screening program. In the study, Inge M.C.M. de Kok of the Department of Public Health at Erasmus MC, University Medical Center in Rotterdam, the Netherlands, and colleagues estimated the costs and effects of adding HPV vaccination to the current program (screening only) using a microsimulation screening analysis model. They found that adding HPV vaccination was not cost-effective, even under favorable assumptions. "To become cost-effective, the vaccine price would have to be decreased considerably, depending on the effectiveness of the vaccine," the authors write. Steve Graff Journal of the National Cancer Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):